PAMG
IBIO icon

Patton Albertson Miller Group’s iBio IBIO Stock Holding History

Patton Albertson Miller Group’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-10
Closed -$28K – 124
2015
Q4 		$28K Hold
10
– – 0.01% 121
2015
Q3 		$34K Hold
10
– – 0.02% 114
2015
Q2 		$48K Hold
10
– – 0.02% 123
2015
Q1 		$38K Sell
10
-3
-23% -$10.2K 0.02% 138
2014
Q4 		$44K Buy
+13
New +$69.4K 0.02% 148

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $242M AUM 20.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
S
SignatureFD Atlanta, Georgia $7.49B AUM 24.82% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Patton Albertson Miller Group's IBIO Position: Q1 2016 in Review

Patton Albertson Miller Group sold out of iBio (IBIO) in Q1 2016, closing a stake of 10 shares — an estimated $28K sold.

Patton Albertson Miller Group first reported a position in IBIO in Q4 2014 and held it in 5 quarters. The position peaked at $48K in Q2 2015. 19 funds tracked by Wall St. Rank hold IBIO as of Q1 2016.

  • Patton Albertson Miller Group reported no remaining iBio position as of Q1 2016 after selling out during the quarter.
  • Patton Albertson Miller Group sold 10 iBio shares in Q1 2016, an estimated $28K.
  • Patton Albertson Miller Group first reported a position in iBio in Q4 2014 and held it in 5 quarters.
  • Patton Albertson Miller Group's iBio position peaked at $48K in Q2 2015.
  • 19 funds tracked by Wall St. Rank held iBio as of Q1 2016.

Based on Patton Albertson Miller Group's 13F filing for Q1 2016, filed 5 May 2016.